Needlescopic Video-Assisted Thoracic Bilateral T4 Sympathicotomy for the Treatment of Primary Palmar Hyperhidrosis: An Analysis of 200 Cases

Feng, Xing; Xiong, Xiufang; Jin, Er; Meng, Wen

doi:10.1055/s-0038-1645872

Cited by 4 publications

(1 citation statement)

References 24 publications

(22 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Success rates of over 90% for curing or improving symptoms of severe palmar hyperhidrosis have been described [24][25][26][27][28]. More recent studies by Chen et al and Feng et al, in which respectively 10.275 and 200 patients with palmar hyperhidrosis were treated with thoracoscopic sympathicotomy, even reported a success rate of 100% [29,30]. Nevertheless, literature comparisons should be interpreted with caution, since in most studies different nomenclature and definitions are used.…”

Section: The Current Status Of Minimally Invasive Sympathicotomy For Palmar Hyperhidrosismentioning

confidence: 99%

Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach

Kuijpers

Zanden

Harms

et al. 2022

JCM

View full text Add to dashboard Cite

Hyperhidrosis, the medical term for excessive sweating beyond physiological need, is a condition with serious emotional and social consequences for affected patients. Symptoms usually appear in focal areas such as the feet, hands, axillae and face. Non-surgical treatment options such as topical antiperspirants or systemic medications are usually offered as a first step of treatment, although these therapies are often ineffective, especially in severe and intolerable cases of hyperhidrosis. In the treatment algorithm for patients suffering from hyperhidrosis, surgical thoracoscopic sympathicotomy offers a permanent solution, which is particularly effective in the treatment of palmar hyperhidrosis and facial blushing. In this review, we describe the current status of thoracoscopic sympathicotomy for palmar hyperhidrosis and facial blushing. In addition, we share the specific treatment approach, technique and results of our Hyperhidrosis Expert Center. Last, we share recommendations to ensure an effective, reproducible and safe application of single-port thoracoscopic sympathicotomy for palmar hyperhidrosis and facial blushing, based on our extensive experience.

show abstract

Section: The Current Status Of Minimally Invasive Sympathicotomy For Palmar Hyperhidrosismentioning

confidence: 99%

Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach

Kuijpers

Zanden

Harms

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

Quality of life after thoracic sympathectomy for palmar hyperhidrosis: a meta-analysis

Wei

2020

Gen Thorac Cardiovasc Surg

View full text Add to dashboard Cite

Quality of life and patient satisfaction after single-port endoscopic thoracic sympathectomy for primary focal hyperhidrosis: a follow-up of 250 patients

Majeed,

Baram,

Izac

2024

International Journal of Surgery Open

View full text Add to dashboard Cite

Background: If left untreated, severe types of primary focal hyperhidrosis (PFH) would have a negative impact on the quality of life (QoL) of the affected person. This study aimed to determine the efficacy of an endoscopic thoracic sympathectomy (ETS) and the degree of improvement in QoL and satisfaction after surgery. The intraoperative and postoperative complications were evaluated, especially compensatory hyperhidrosis (CH). We hypothesized that the selected sympathectomy levels will neither prevent nor reduce CH. Methods: A single-center retrospective study of 250 adult patients diagnosed with bilateral PFH underwent ETS of the second, third, and fourth thoracic sympathetic ganglion. We compared preoperative and postoperative hyperhidrosis severity score (HDSS) and QoL using Pearson correlation. The rate of CH and other complications during follow-up of 4 years were recorded. Results: Among 250 patients, 217 had a preoperative HDSS of three and 33 patients had a score of 4, when compared postoperatively HDSS was 0 in 145 patients (58%), one in 82 patients (32.8%), two in 22 patients (8.8%), and score 3 in one patient (0.4%) (P=0.097). QoL before operation in 201 patients was very bad (80.4%), while postoperatively, QoL was much better in 206 patients (82.4%) (P=0.0001). CH was seen only in 27 patients (10.8%), and only one was severe. Conclusion: ETS is safe and effective for severe cases of PFH. Sympathectomy at second, third, and fourth ganglion levels has an excellent outcome and higher patient satisfaction with minimal perioperative complications, including CH.

show abstract

Needlescopic Video-Assisted Thoracic Bilateral T4 Sympathicotomy for the Treatment of Primary Palmar Hyperhidrosis: An Analysis of 200 Cases

Abstract: Needlescopic video-assisted thoracic bilateral T4 sympathicotomy could reach an excellent and immediate result of treating PPH. It is a safe, convenient, and minimally invasive method appropriate for wide clinical use.

Cited by 4 publications

References 24 publications

Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach

Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach

Quality of life after thoracic sympathectomy for palmar hyperhidrosis: a meta-analysis

Quality of life and patient satisfaction after single-port endoscopic thoracic sympathectomy for primary focal hyperhidrosis: a follow-up of 250 patients

Contact Info

Product

Resources

About